Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 18, 2005

View Archived Issues

Janex-1 reduces tumorigenesis and improves survival in a mouse model of FAP

New phase II data on the efficacy of 3-AP plus gemcitabine in pancreatic cancer

February meeting of European Committee for Orphan Medicinal Products

Aceon sNDA accepted for filing with priority review

Positive data from phase IIa BrachySil study

Evotec to provide process validation for AMD-3100

Entelos and Organon to extend rheumatoid arthritis collaboration

New collaboration to conduct whole genome association study on breast cancer

Galenea and Otsuka team up for CNS drug discovery efforts

Milestone in Cellular Genomics kinase discovery program with Serono

WinRho SDF shows promise for dengue hemorrhagic fever

OctoPlus and Biolex to jointly develop controlled-release alfa interferon

Enrollment completed in phase II HCV study of Albuferon

Endpoints met in phase III study of indiplon MR for chronic insomnia

Dutch approval for Draxis' diagnostic radiopharmaceutical

FDA reveals safety reviews of etoricoxib, lumiracoxib and parecoxib

Supportive care reported to improve the safety profile of nolatrexed in HCC patients

Clinical evidence on cardiovascular risk with COX-2 inhibitors / News in Context

A subcutaneous histrelin implant shows promise in the treatment of CPP

Excessive scarring prevented by 4-hydroxy tamoxifen (4-OHT)

Transnasal micro-emulsions of diazepam claimed by SK Corporation scientists

Novel factor Xa (FXa) inhibitors discovered at Merck KGaA

Neurogen researchers develop new GABA-A receptor modulators

Two series of beta-2 adrenoreceptor agonists prepared and tested at Pfizer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...